SciencePharma was established in 2004 in Warsaw. From that time, it is in dynamic process of development, constantly expanding number of satisfied clients from Poland and other countries, as well as scope of services. During years of business, we have become the leader in polish consultancy companies, which offer specialized and client-tailored consulting services for pharma industry.
SciencePharma started its operations with only a few team members and with time grew to over 90 qualified experts ready for complex pharmaceutical projects. We are looking brightly into our future plans and ideas. Our next steps will be to expand further in the field of biotechnology drugs, ATMPs or cannabis, by taking part in more advanced project.
First successful national registration procedure
Over 300 registration dossiers for the harmonization process (obligatory after PL joins the EU)
GCP and GLP audits; first BEQ studies, dossier for biotech product
EU-funded R&D projects
First GMP audits
First pre-clinical studies
First clinical trials as a CRO and GCP system implementation for clinical trials
First preparation of IMPD for ATMP
First in the EU OTC switch with a proprietary diagnostic tool validated in a clinical trial
First marketing authorization in the EU for enoxaparin biosimilar
First dossier preparation for Cannabis
First support in notification/ certification for medical device
First online GMP audits
Adjustment services with the challenges of the pharmaceutical industry resulting from Brexit
Expanding operations on new EU and non-EU markets, development of Market Access services, further improvement in the subject of ATMP, nanotechnology and cannabis.